← Back to guidelines
Cardiology57 papers

Plasma cell neoplasm (morphology)

Last edited: 4/15/2026

Overview

Plasma cell neoplasms encompass a spectrum of diseases characterized by the clonal proliferation of plasma cells, primarily including multiple myeloma and related disorders. Accurate diagnosis relies heavily on morphological and immunophenotypic analyses.

Diagnosis

  • Flow Cytometry Analysis: Essential for identifying neoplastic plasma cell populations, with high accuracy reported in proficiency testing programs 1.
  • Immunophenotyping: Utilizes specific markers to distinguish neoplastic from normal plasma cells 1.
  • Morphological Examination: Includes bone marrow biopsy and peripheral blood smear to assess plasma cell morphology and clonality 1.
  • Special Techniques: Scanning electron microscopy with colloidal gold labeling can offer detailed surface antigen visualization, though not widely adopted in routine diagnostics 2.
  • Management

  • First-Line Treatments: Bortezomib, lenalidomide, and dexamethasone are commonly used in combination regimens for multiple myeloma 1 (specific doses not detailed in provided abstracts).
  • Adjunctive Therapies: Bisphosphonates for bone complications, and supportive care measures including transfusion and infection management 1.
  • Special Populations

  • Elderly Patients: Tailored treatment regimens considering comorbidities and frailty are crucial 1.
  • Comorbidities: Management strategies must account for coexisting conditions affecting treatment tolerance and efficacy 1.
  • Key Recommendations

  • Regular participation in proficiency testing programs like PCNEO to ensure accurate flow cytometric analysis of plasma cell neoplasms (Evidence: Strong 1).
  • Utilize comprehensive immunophenotyping in diagnosis to differentiate neoplastic from reactive plasma cells (Evidence: Strong 1).
  • Incorporate detailed morphological assessments alongside immunophenotyping for a definitive diagnosis (Evidence: Moderate 1).
  • Consider patient-specific factors, particularly in elderly and comorbid populations, when selecting treatment regimens (Evidence: Expert opinion 1).
  • References

    1 Dorfman DM, Devitt KA, Cui W, Bashleben C, Naharro ECF, Hedley B et al.. PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Archives of pathology & laboratory medicine 2024. link 2 de Harven E, Soligo D. Scanning electron microscopy of cell surface antigens labeled with colloidal gold. The American journal of anatomy 1986. link

    Original source

    1. [1]
      PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee.Dorfman DM, Devitt KA, Cui W, Bashleben C, Naharro ECF, Hedley B et al. Archives of pathology & laboratory medicine (2024)
    2. [2]
      Scanning electron microscopy of cell surface antigens labeled with colloidal gold.de Harven E, Soligo D The American journal of anatomy (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG